Pawlik et al developed a prognostic score for predicting survival in a patient with hepatocellular carcinoma following surgical resection. The authors are from the International Cooperative Study Group on Hepatocellular Carcinoma.
Parameters:
(1) serum alpha-fetoprotein (AFP) in ng/mL
(2) major vascular invasion (gross invasion of the right or left main branches of the hepatic or portal veins)
(3) number of hepatic tumor nodules
(4) degree of hepatic fibrosis (graded 0 to 6 using the scheme of Ishak et al, with complete bridging fibrosis grade 5 and cirrhosis grade 6)
Parameter |
Finding |
Points |
serum AFP |
< 1,000 ng/mL |
0 |
|
>= 1,000 ng/mL |
1 |
major vascular invasion |
absent |
0 |
|
present |
1 |
number of tumor nodules |
1 |
0 |
|
>= 2 |
1 |
hepatic fibrosis |
complete bridges or cirrhosis absent |
0 |
|
complete bridges or cirrhosis present (Ishak grade 5 or 6) |
1 |
total number of risk factors =
= SUM(points for all 4 parameters)
Interpretation:
• minimum total score: 0
• maximum total score: 4
• The higher the score the worse the survival.
Number of Risk Factors |
Prognostic Score |
Median Survival |
0 |
1 |
60 months |
1 or 2 |
2 |
19 months |
3 or 4 |
3 |
10 months |
After 6 years the survival curves for prognostic scores 2 and 3 become similar with survival at 10 years about 10%.
Performance:
• Survival based on T classification showed 3 groups (T1, T2, T3-4) which stratified survival better (Figure 5, page 454) with T1 good (median survival 60 months), T2 fair and T3-T4 poor.
• The prognostic score should not be used to exclude patients from surgical resection since some patients have a more favorable T stage.
Limitations:
• The method and normal reference range for serum AFP was not given.
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
ICD-10: ,